Blocking Ace2 Sars

ACE2 (SARS Receptor) Antibody

abx032686-400ul 400 ul
EUR 627.6

Human IgG antibody Laboratories manufactures the blocking ace2 sars reagents distributed by Genprice. The Blocking Ace2 Sars reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Blocking. Other Blocking products are available in stock. Specificity: Blocking Category: Ace2 Group: Sars

ACE2 Antibody

100ul
EUR 468

ACE2 Antibody

100ul
EUR 468

ACE2 Antibody

200ul
EUR 420

ACE2 antibody

50 ul
EUR 522
Description: Rabbit polyclonal ACE2 antibody

ACE2 antibody

50 ug
EUR 560.4
Description: Rabbit polyclonal ACE2 antibody

ACE2 Antibody

100ul
EUR 302.4

ACE2 Antibody

100ul
EUR 468

Sars information

SAR1B Blocking Peptide

33R-8038 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SAR1B antibody, catalog no. 70R-3167

SAR1A Blocking Peptide

DF9554-BP 1mg
EUR 234

SAR1B Blocking Peptide

DF4105-BP 1mg
EUR 234

Acetyl-FKHR(K294) Blocking Peptide

AF2305-BP 1mg
EUR 234

Acetyl-H2B (Lys16) Blocking Peptide

AF4356-BP 1mg
EUR 234

Acetylcholinesterase Blocking Peptide

20-abx062201
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

Acetyl-p53 (Lys317) Blocking Peptide

AF1024-BP 1mg
EUR 234

Acetyl-p53 (Lys373) Blocking Peptide

AF4363-BP 1mg
EUR 234

Acetyl-p53 (Lys381) Blocking Peptide

AF4364-BP 1mg
EUR 234

Spike S1-Biotin (SARS-CoV-2): ACE2 TR-FRET Assay Kit

79949-1 96 rxns.
EUR 905
Description: The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As a first step of the viral replication strategy, the virus attaches to the host cell surface before entering the cell. The Spike protein recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer some protection against the viral infection._x000D_The SARS-CoV-2 Spike S1:ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between SARS-CoV-2 Spike S1 and human ACE2 in a homogeneous 96 or 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, dye-labeled acceptor and an inhibitor for one hour. Then the TR-FRET signal is measured using a fluorescence reader._x000D_ 

Spike S1-Biotin (SARS-CoV-2): ACE2 TR-FRET Assay Kit

79949-2 384 rxns.
EUR 1265
Description: The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As a first step of the viral replication strategy, the virus attaches to the host cell surface before entering the cell. The Spike protein recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer some protection against the viral infection._x000D_The SARS-CoV-2 Spike S1:ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between SARS-CoV-2 Spike S1 and human ACE2 in a homogeneous 96 or 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, dye-labeled acceptor and an inhibitor for one hour. Then the TR-FRET signal is measured using a fluorescence reader._x000D_ 

SARDH Blocking Peptide

33R-1982 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SARDH antibody, catalog no. 70R-1188

SARNP Blocking Peptide

DF12899-BP 1mg
EUR 234

SART1 Blocking Peptide

DF9978-BP 1mg
EUR 234

SART3 Blocking Peptide

DF8829-BP 1mg
EUR 234

Acetyl-Histone H4 (Lys5) Blocking Peptide

AF3355-BP 1mg
EUR 234

Acetyl-Histone H3(Lys9) Blocking Peptide

AF3359-BP 1mg
EUR 234